These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15735237)

  • 1. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.
    Blumer I
    Diabetes Care; 2005 Mar; 28(3):763; author reply 763-4. PubMed ID: 15735237
    [No Abstract]   [Full Text] [Related]  

  • 2. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2005 Jul; 28(7):1834-5. PubMed ID: 15983352
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.
    Pickup J; Mattock M; Kerry S
    BMJ; 2002 Mar; 324(7339):705. PubMed ID: 11909787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?
    Currie CJ
    Diabet Med; 2007 Oct; 24(10):1058-9. PubMed ID: 17888127
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.
    Maiorino MI; Petrizzo M; Bellastella G; Esposito K
    Endocrine; 2018 Jan; 59(1):62-65. PubMed ID: 28551774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term glucose variability in adults with Type 1 diabetes does not differ between insulin pump and multiple daily injection users - a masked continuous glucose monitoring study in clinical practice.
    Scott ES; McGrath RT; Januszewski AS; Fulcher GR; Jenkins AJ
    Diabetes Metab; 2020 Apr; 46(2):172-174. PubMed ID: 29937359
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin glulisine for continuous subcutaneous insulin infusion in pediatric type 1 diabetes.
    Urakami T; Mine Y; Aoki M; Okuno M; Suzuki J
    Pediatr Int; 2017 May; 59(5):647-649. PubMed ID: 28544684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies.
    Dodesini AR; Cavalli G; Ciriello E; Lepore G; Corsi A; Scaranna C; Bellante R; Albizzi M; Galliani S; Mangili G; Trevisan R
    J Diabetes; 2020 Nov; 12(11):860-861. PubMed ID: 32594625
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.
    Hood DG
    Nurs Womens Health; 2012; 16(4):308-18. PubMed ID: 22900807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific advantages of continuous subcutaneous insulin infusion as compared with multiple daily injections in pediatric patients: one-year follow-up comparison by matched-pair analysis.
    Kordonouri O; Hartmann R; Lauterborn R; Barnekow C; Hoeffe J; Deiss D
    Diabetes Care; 2006 Jan; 29(1):133-4. PubMed ID: 16373909
    [No Abstract]   [Full Text] [Related]  

  • 13. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK: Response to Roze et al.
    DeVries JH
    Diabet Med; 2006 Jun; 23(6):709; author reply 708. PubMed ID: 16759318
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application and practice of intensive insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Devices in Insulin Delivery.
    Meneghini LF; McNulty JN
    Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin doses adaptation with insulin Lys-pro in external pump].
    Grimaldi A; Sachon C; Timsit J
    Diabetes Metab; 2001 Jun; 27(3):386-7. PubMed ID: 11431606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Continuous subcutaneous insulin infusion].
    Ito H; Kanatsuka A
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract]   [Full Text] [Related]  

  • 18. Tailoring intensified insulin therapy in children.
    Danne T
    Pediatr Diabetes; 2009 Aug; 10(5):295-7. PubMed ID: 19682282
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.